4.0
4. Apr. 2022
Aktueller Mitarbeiter, mehr als 1 Jahr
Menlo Park, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Very employee-friendly. Lots of opportunity to learn all aspects of drug-development due to high level of internal transparency. Very committed to R&D and specifically precision-medicine.
Kontras
Some uncertainty around Chinese-led companies with operations in the US.